Neogen (NEOG) Set to Post Earnings on Tuesday

Neogen (NASDAQ:NEOG – Get Free Report) will likely be issuing its Q1 2027 results before the market opens on Tuesday, October 6th. Analysts expect Neogen to announce earnings of $0.0533 per share and revenue of $208.1750 million for the quarter. Individuals can find conference call details on the company’s upcoming Q1 2027 earning results page for the latest details on the call scheduled for Tuesday, October 6, 2026 at 4:30 PM ET.

Neogen (NASDAQ:NEOG – Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.03. Neogen had a negative net margin of 0.91% and a positive return on equity of 2.78%. The business had revenue of $225.30 million for the quarter, compared to analyst estimates of $212.35 million. During the same quarter in the prior year, the firm earned ($2.82) EPS. The firm’s quarterly revenue was down .1% compared to the same quarter last year. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Get Neogen alerts:

Neogen Stock Performance

Shares of NEOG stock opened at $12.15 on Monday. The company has a market capitalization of $2.65 billion, a P/E ratio of -405.00, a P/E/G ratio of 4.56 and a beta of 1.79. Neogen has a 12-month low of $5.37 and a 12-month high of $14.26. The company has a quick ratio of 2.91, a current ratio of 3.82 and a debt-to-equity ratio of 0.38. The firm has a 50-day moving average price of $11.95 and a 200 day moving average price of $10.20.

Wall Street Analyst Weigh In

NEOG has been the topic of several recent analyst reports. Weiss Ratings raised Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Guggenheim reissued a “buy” rating and issued a $14.00 price objective (up from $12.00) on shares of Neogen in a research note on Wednesday. Piper Sandler upgraded Neogen from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $13.00 to $14.00 in a report on Wednesday, August 26th. Finally, Wall Street Zen raised Neogen from a “buy” rating to a “strong-buy” rating in a report on Saturday. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $12.67.

View Our Latest Report on NEOG

About Neogen

(Get Free Report)

Neogen Corporation is a global provider of food safety and animal safety products and services. The company develops diagnostic tests, laboratory products, and related solutions that help customers detect foodborne pathogens, allergens, toxins, residues, and other contaminants throughout the food production process.

Its food safety portfolio includes test kits, culture media, molecular testing systems, sanitation monitoring products, and laboratory supplies used by food manufacturers, processors, retailers, and regulatory organizations.

See Also

• Five stocks we like better than Neogen
• Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
• The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It
• McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers?
• MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.